Cargando…
Emerging treatment options for meibomian gland dysfunction
Meibomian gland dysfunction (MGD) is one of the most common diseases observed in clinics; it influences a great number of people, and is the leading cause of evaporative dry eye. Given the increased recognition of the importance of MGD, a great amount of attention has been paid to therapies targetin...
Autores principales: | Qiao, Jing, Yan, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772773/ https://www.ncbi.nlm.nih.gov/pubmed/24043929 http://dx.doi.org/10.2147/OPTH.S33182 |
Ejemplares similares
-
Non‐pharmaceutical treatment options for meibomian gland dysfunction
por: Arita, Reiko, et al.
Publicado: (2020) -
A Retrospective Study of Treatment Outcomes and Prognostic Factors of Intense Pulsed Light Therapy Combined With Meibomian Gland Expression in Patients With Meibomian Gland Dysfunction
por: Tang, Yun, et al.
Publicado: (2021) -
Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction
por: Maskin, Steven L, et al.
Publicado: (2018) -
Meibomian gland dysfunction, dropout and distress: emerging therapies
por: Hassan, Ali, et al.
Publicado: (2020) -
Therapeutic Instruments Targeting Meibomian Gland Dysfunction
por: Valencia-Nieto, Laura, et al.
Publicado: (2020)